Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Thursday’s insider buys and sells: Healthcare and tech in focus By Investing.com - Investing.com India
Thursday’s insider buys and sells: Healthcare and tech in focus By Investing.comInvesting.com India
Sagility gains after arm signs pact to acquire US-based CareSeed
Sagility added 1.73% to Rs 39.32 after its step-down subsidiary, Sagility LLC has signed a definitive agreement to acquire US-based CareSeed, a healthcare analytics firm.
Cochin Shipyard among 5 F&O stocks with a sharp rise in futures open interest
Futures open interest in the NSE F&O segment rose sharply on June 11, with five stocks recording over 5% growth. Cochin Shipyard led the list, followed by Max Healthcare, Amber Enterprises, Nuvama Wealth, and Manappuram Finance, indicating fresh position build-up and heightened trading activity in select counters.

Sagility acquires CareSeed to strengthen AI-led healthcare quality operations in US
Shares of Sagility Ltd ended at ₹39.39, down by ₹0.74, or 1.84%, on the BSE.
Manipal Health leases Bengaluru hospital asset on nearly 30-year pact
Manipal Health Enterprises has secured a large hospital building in Bengaluru on a long-term lease. The deal spans almost 30 years, with a total rental commitment of around Rs 500 crore. This expansion follows recent acquisitions and property deals. The company is growing its network to meet rising healthcare demand.
CapitalNumbers Infotech gains after securing UK AI Healthcare project order
CapitalNumbers Infotech rallied 3.39% to Rs 112 after it has secured an international order worth Rs 2.46 crore from a UK-based entity for an artificial intelligence project in the healthcare domain.
Alembic Pharmaceuticals receives USFDA tentative approval for Larotrectinib Capsules
Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of Bayer Healthcare Pharmaceuticals Inc. (Bayer).

Infosys Ties Up With IHH Healthcare For AI Led Growth
Through a partnership with Infosys, IHH seeks to standardise business processes across all its markets starting with Hong Kong, Malaysia, and Singapore.
Aegis Logistics Ltd leads gainers in 'A' group
Blue Jet Healthcare Ltd, Wockhardt Ltd, DOMS Industries Ltd and Apar Industries Ltd are among the other gainers in the BSE's 'A' group today, 11 June 2026.
Analysts project up to 17% upside in healthcare stocks trading at new highs
Apollo Hospitals, Aster DM Healthcare, Sai Life Sciences have rallied up to 27% thus far in FY27; technical analysts remain bullish on these stocks given the favourable chart set-up.
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplash
Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic demand and positive global healthcare trends. Analysts see long-term growth potential from aging populations and innovation. Emerging opportunities from supply chain diversification away from China also present a positive outlook for Indian pharmaceutical companies.

Nifty 50 target cut by Citi to 26,000 - Key risk factors, top picks explained
Citi has highlighted Financials, Telecom, Healthcare, Defence and Utilities as their key "overweights", while IT Services, Staples, Metals are their top "underweights." It has also added Hitachi Energy into its list of top picks having initiated coverage on the stock recently.